These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36989566)

  • 1. Clinical characteristics of 80 subjects with KCNQ2-related encephalopathy: Results from a family-driven survey.
    Cossu A; Lo Barco T; Proietti J; Dalla Bernardina B; Cantalupo G; Ghobert L; Brambilla I; Giarola E; Costa A; De Benito T; Bethge S; Cardot S; Montwill I; Remonato E; Gramaglia S; Darra F
    Epilepsy Behav; 2023 May; 142():109153. PubMed ID: 36989566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic analysis of 18 patients with
    Cao B; Peng B; Tian Y; Wang X; Li X; Zhu H; Shen H; Chen W
    Turk J Pediatr; 2024 May; 66(2):191-204. PubMed ID: 38814296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of KCNQ2 encephalopathy.
    Kim HJ; Yang D; Kim SH; Won D; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
    Brain Dev; 2021 Feb; 43(2):244-250. PubMed ID: 32917465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capturing seizures in clinical trials of antiseizure medications for
    Millichap JJ; Harden CL; Dlugos DJ; French JA; Butterfield NN; Grayson C; Aycardi E; Pimstone SN
    Epilepsia Open; 2021 Mar; 6(1):38-44. PubMed ID: 33681646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship Between Epileptic Activity and Developmental Outcome in KCNQ2-Related Epilepsy.
    Casas-Alba D; Aguilar A; Alonso I; García MT; Cilio MR; Fons C;
    Pediatr Neurol; 2023 Jul; 144():11-15. PubMed ID: 37099824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezogabine impacts seizures and development in patients with KCNQ2 developmental and epileptic encephalopathy.
    Knight D; Mahida S; Kelly M; Poduri A; Olson HE
    Epilepsia; 2023 Jul; 64(7):e143-e147. PubMed ID: 37096745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted gene panel sequencing in early infantile onset developmental and epileptic encephalopathy.
    Na JH; Shin S; Yang D; Kim B; Kim HD; Kim S; Lee JS; Choi JR; Lee ST; Kang HC
    Brain Dev; 2020 Jun; 42(6):438-448. PubMed ID: 32139178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and effective treatment of KCNQ2 encephalopathy.
    Pisano T; Numis AL; Heavin SB; Weckhuysen S; Angriman M; Suls A; Podesta B; Thibert RL; Shapiro KA; Guerrini R; Scheffer IE; Marini C; Cilio MR
    Epilepsia; 2015 May; 56(5):685-91. PubMed ID: 25880994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic analysis of 23 Chinese children with epilepsy associated with KCNQ2 gene mutations.
    Yu X; Che F; Zhang X; Yang L; Zhu L; Xu N; Qiu S; Li Y
    Epilepsia Open; 2024 Oct; 9(5):1658-1669. PubMed ID: 39141400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation.
    Kato M; Yamagata T; Kubota M; Arai H; Yamashita S; Nakagawa T; Fujii T; Sugai K; Imai K; Uster T; Chitayat D; Weiss S; Kashii H; Kusano R; Matsumoto A; Nakamura K; Oyazato Y; Maeno M; Nishiyama K; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Saito K; Hayasaka K; Matsumoto N; Saitsu H
    Epilepsia; 2013 Jul; 54(7):1282-7. PubMed ID: 23621294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of KCNQ2 variants causing either benign neonatal epilepsy or developmental and epileptic encephalopathy.
    Goto A; Ishii A; Shibata M; Ihara Y; Cooper EC; Hirose S
    Epilepsia; 2019 Sep; 60(9):1870-1880. PubMed ID: 31418850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant.
    Millichap JJ; Miceli F; De Maria M; Keator C; Joshi N; Tran B; Soldovieri MV; Ambrosino P; Shashi V; Mikati MA; Cooper EC; Taglialatela M
    Epilepsia; 2017 Jan; 58(1):e10-e15. PubMed ID: 27861786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable expressivity of a likely pathogenic variant in KCNQ2 in a three-generation pedigree presenting with intellectual disability with childhood onset seizures.
    Hewson S; Puka K; Mercimek-Mahmutoglu S
    Am J Med Genet A; 2017 Aug; 173(8):2226-2230. PubMed ID: 28602030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KCNQ2 mutations in childhood nonlesional epilepsy: Variable phenotypes and a novel mutation in a case series.
    Lee IC; Chang TM; Liang JS; Li SY
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00816. PubMed ID: 31199083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiepileptic therapy approaches in KCNQ2 related epilepsy: A systematic review.
    Kuersten M; Tacke M; Gerstl L; Hoelz H; Stülpnagel CV; Borggraefe I
    Eur J Med Genet; 2020 Jan; 63(1):103628. PubMed ID: 30771507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KCNQ2 related early-onset epileptic encephalopathies in Chinese children.
    Fang ZX; Zhang M; Xie LL; Jiang L; Hong SQ; Li XJ; Hu Y; Chen J
    J Neurol; 2019 Sep; 266(9):2224-2232. PubMed ID: 31152295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar early characteristics but variable neurological outcome of patients with a de novo mutation of KCNQ2.
    Milh M; Boutry-Kryza N; Sutera-Sardo J; Mignot C; Auvin S; Lacoste C; Villeneuve N; Roubertie A; Heron B; Carneiro M; Kaminska A; Altuzarra C; Blanchard G; Ville D; Barthez MA; Heron D; Gras D; Afenjar A; Dorison N; Doummar D; Billette de Villemeur T; An I; Jacquette A; Charles P; Perrier J; Isidor B; Vercueil L; Chabrol B; Badens C; Lesca G; Villard L
    Orphanet J Rare Dis; 2013 May; 8():80. PubMed ID: 23692823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyridoxine-responsive KCNQ2 epileptic encephalopathy: Additional cases and literature review.
    Chen J; Tao Q; Fan L; Shen Y; Liu J; Luo H; Yang Z; Liang M; Gan J
    Mol Genet Genomic Med; 2022 Oct; 10(10):e2024. PubMed ID: 35906921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KCNQ2-Related Epilepsy: Genotype-Phenotype Relationship with Tailored Antiseizure Medication (ASM)-A Systematic Review.
    Falsaperla R; Criscione R; Cimino C; Pisani F; Ruggieri M
    Neuropediatrics; 2023 Oct; 54(5):297-307. PubMed ID: 36948217
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.